Phibro Animal Health | PAHC - 流动资产

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 2.37B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	流动资产	更改		日
Align Technology	USD 2.66B		38.87M	2026-03
ANI Pharmaceuticals	USD 753.12M		54.72M	2025-12
Assertio Holdings	USD 263.57M		53.36M	2025-09
Aurora Cannabis	CAD 445.84M		22M	2025-12
Bristol-Myers Squibb	USD 27.21B		2.18B	2026-03
Canopy Growth	CAD 524.67M		78.85M	2025-12
Corcept Therapeutics	USD 426.03M		59.43M	2026-03
Eli Lilly	USD 54.84B		794M	2026-03
Henry Schein	USD 4.5B		32M	2026-03
Idexx Laboratories	USD 1.45B		40.25M	2026-03
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Merck	USD 35.02B		8.5B	2026-03
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Pacira	USD 514.96M		33.01M	2026-03
Phibro Animal Health	USD 894.07M		31.88M	2026-03
Prestige Brands	USD 433.43M		63.98M	2025-12
Supernus Pharmaceuticals	USD 731.58M		87.4M	2026-03
Zoetis	USD 6.47B		294M	2026-03